President wants $309 million in 2016 for initiative
More research is needed to find out why
The NIH begins using its Siemens Somatom Count in clinical studies
Will move research from lab to clinic
First human tests find that simple, biodegradable glucose compound finds tumors
From the Jan/Feb issue of HCB News magazine
Transactions will be completed in first quarter of 2017
From the Jan/Feb issue of HCB News magazine
Vendor-neutral hybrid storage solution for imaging data, EHRs
Found guilty of health care fraud leading to two deaths
At issue are referral kickback allegations
From the Jan/Feb issue of HCB News magazine
Designed to help physicians pace from optimal site
Faster, less invasive? Or slightly better dose distribution?
Reportedly had five beers at a casino before his 'on-call' pager went off
'One of the largest whistleblower lawsuits in the U.S.'
Out on bail after giving a physical to an undercover agent
Determining treatment candidacy up to 18 hours post-stroke
Breaking down the inefficient allocation of resources
Breaking down silos without compromising performance
May improve access to guided biopsies
Evidence suggests improved outcomes three years later
Making strides toward adaptive proton therapy treatment
Embracing the IT benefits of server-based image rendering
Trends for optimizing imaging systems for a facility's diagnostic users
Momentum building for proton therapy — and its major OEMs
Algorithm has 14 percent better chance of diagnosing the disease than a doctor
Discover the namesake of Hodgkin's disease
Teaming up for better clinical decision support
Computer giant's fourth major health data-related acquisition in 12 months
Complements research collab between MIT and Philips
Bad ergonomics can be a serious pain in the neck
Our brains may be trying to get us back to rewarding circumstances
The ESCVD Risk Estimator helps manage the deluge of health data
Hollywood Presbyterian calls previous price reports 'false'
From the Jan/Feb issue of HCB News magazine
Could be a landmark ruling in the way drugs are prescribed in the U.S.
Company continues expansion with third acquisition announced this month
Weighing high value against high cost
Lack of adherence is the problem